ISPOR 16th ANNUAL INTERNATIONAL MEETING AWARDS WINNERS

 

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated over 56 podium presentations and over 100 nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 20%, based on abstract review score, are considered and eligible for a poster presentation award.
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation
A special thanks goes to David Thompson PhD, Vice President, Global Health Economics, i3 Innovus, Medford, MA, USA, ISPOR Podium and Poster Research Presentation Awards Committee -- Podium Research Presentations, AS WELL AS TO, Elizabeth Manias PhD, RPh, Professor, The University of Melbourne, Victoria Australia, and Chair, ISPOR Podium and Poster Research Presentation Awards Committee -- Poster Research Presentations, for all their efforts in selecting the recipients!


THE RECIPIENTS  ARE: . . .

ISPOR Best Podium Research Presentation Awards

Best General Podium Presentations

CE3 - COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ASSESSMENT: A GRAPHICAL WAY TO COMBINE THE TWO FOR THE AID OF DECISION MAKERS
Paulden M, Pham B
University of Toronto, Toronto, ON, Canada

EE3 - PERFORMANCE OF DIFFERENT COMORBIDITY MEASURES IN PREDICTING HEALTHCARE EXPENDITURE IN PATIENTS WITH DEMENTIA
Johnson ML, Mehta S, Chitnis AS, Bhowmik D, Dwibedi N, Kamble P
University of Houston, Houston, TX, USA

IN3 - COSTS ASSOCIATED WITH HCV AND RELATED COMPLICATIONS IN THE UNITED STATES FROM A MANAGED CARE PAYER'S PERSPECTIVE
Biskupiak J1, McAdam Marx C1, Hane CA2, Deniz B3, McGarry L4, Brixner D1
1University of Utah, Salt Lake City, UT, USA, 2Ingenix, Eden Prairie, MN, USA, 3Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA, 4i3 Innovus, Medford, MA, USA

Best Student Podium Research Presentations

  IN4 - CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS – A COST-EFFECTIVENESS ANALYSIS
Nolte JEH1, Neumann T2, Neumann A3, Manne J4, Mostardt S3, Abbara S5, Brady TJ5, Hoffmann U5, Gazelle GS1, Wasem J3, Goehler A1
1Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 2University Hospital Essen, Essen, Germany, 3University Duisburg-Essen, Essen, Germany, 4Harvard School of Public Health, Boston, MA, USA, 5Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

EE2 - VALIDATION OF THE UPDATED CHARLSON COMORBIDITY INDEX (CCI) TO PREDICT HEALTHCARE UTILIZATION FOR DIABETIC PATIENTS USING ADMINISTRATIVE DATA
Cheng LI1, Rascati KL1, Trice S2, Lawson K1, Barner JC1
1The University of Texas at Austin, Austin, TX, USA, 2Department of Defense, Fort Sam Houston, TX, USA

MC3 - IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIAS
An JJ, Nichol MB
University of Southern California, Los Angeles, CA, USA

Best New Investigator Podium Research Presentations

OR4 - ASSOCIATIONS BETWEEN JOBLESSNESS AND ALL-CAUSE HEALTH SERVICES UTILIZATION IN US DIABETIC WORKING AGE ADULTS
Davis-Ajami ML1, Nahata M1, Seiber E1, Reardon G2, Balkrishnan R3
1The Ohio State University, Columbus, OH, USA, 2Informagenics, LLC, Worthington, OH, USA, 3University of Michigan, Ann Arbor, MI, USA
DU2 - PREVALENCE AND PREDICTORS OF POTENTIALLY SIGNIFICANT DRUG-DRUG INTERACTIONS IN THE ELDERLY
Dudash K1, Negri G2, Baccarini S3, Rabinowitz C1, Maio V1
1Thomas Jefferson University, Philadelphia, PA, USA, 2Local Health Authority Parma, Parma, Italy, 3Ospedale di Fidenza - San Secondo, Fidenza, Parma, Italy
DM2 - 12-MONTH OUTCOMES OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM
Moczygemba L1, Barner JC2, Gabrillo E3
1Virginia Commonwealth University, Richmond, VA, USA, 2The University of Texas at Austin, Austin, TX, USA, 3Scott & White Health Plan Prescription Services, Temple, TX, USA


ISPOR Best Poster Research Presentation Awards

Best General Poster Research Presentations

PRM16 - VALIDATION AND PSYCHOMETRIC EVALUATION OF A 5-ITEM MEASURE OF PERCEIVED SOCIAL SUPPORT
McCarrier KP1, Bushnell DM1, Martin ML1, Paczkowski R2, Nelson DR2, Buesching D2
1Health Research Associates, Inc., Mountlake Terrace, WA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA

PMS46 - IMPACT OF ETANERCEPT ON WORK AND ACTIVITY IMPAIRMENT IN EMPLOYED PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Watson C1, Cheng A2, Hone D3, Huang B3, Bitman B1, Huang XY1, Gandra SR1
1Amgen, Inc., Thousand Oaks, CA, USA, 2McKesson Corporation, East Palo Alto, CA, USA, 3McKesson Specialty, Toronto, ON, Canada
PMS57 - ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS
Han C3, Keystone E1, Fleischmann R2, Smolen JS4, Emery P5, Genovese M6, Gathany T3, Doyle M7, Hsia E7
1Mount Sinai Hospital, Toronto, ON, Canada, 2University of Texas, Dallas, TX, USA, 3Johnson & Johnson Pharmaceutical Services, LLC, Malvern, PA, USA, 4Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 5University of Leeds, Leeds, UK, 6Stanford University, Palo Alto, CA, USA, 7Centocor R&D, Inc, Malvern, PA, USA

Best Student Poster Research Presentations

PMH45 - MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIA
Kim DN, Park H, Rascati KL
University of Texas at Austin, Austin, TX, USA

PSY51 - EFFECTIVENESS OF FDA'S NEW OVER-THE-COUNTER ACETAMINOPHEN LABEL WARNING REQUIREMENTS IN IMPROVING CONSUMER RISK PERCEPTION OF LIVER DAMAGE
Goyal RK1, Rajan SS2, Essien EJ2, Sansgiry S2
1University of North Carolina, Chapel Hill, NC, USA, 2University of Houston, Houston, TX, USA

PIH7 - POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG OLDER ADULTS IN THE UNITED STATES IN 2007
Zhang YJ1, Liu WW2, Guo JJ1
1University of Cincinnati, Cincinnati, OH, USA, 2Academy of Military Medical Sciences, Beijing, China

Best New Investigator Poster Research Presentations

PRM3 - THE BURDEN OF CAREGIVING: ASSESSING THE STATUS OF CURRENT CLINICAL RESEARCH
Hamer N, Costello S, Roper S, Hamerslag L Costello Medical Consulting Ltd, Cambridge, UK

PMD18 - THE COST-EFFECTIVENESS OF INITIATING SENSOR-AUGMENTED PUMP THERAPY VERSUS MULTIPLE DAILY INJECTIONS OF INSULIN IN ADULTS WITH TYPE 1 DIABETES: EVALUATING A TECHNOLOGY IN EVOLUTION
Kamble S1, Perry BM2, Shafiroff J2, Schulman KA1, Reed SD1
1Duke Clinical Research Institute, Durham, NC, USA, 2Medtronic Diabetes, Northridge, CA, USA

PSU12 - IMMUNOSUPPRESSANT THERAPY ADHERENCE AND REJECTION OUTCOMES IN LIVER AND KIDNEY TRANSPLANT PATIENTS
Gorevski E, Minkara A, Bian B, Mogilishetty G, Martin Boone J
University of Cincinnati, Cincinnati, OH, USA

 

ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.

 

Return to ISPOR Awards Index Page